Financial Planning for Millennials: Yes, You Can Afford It
Rising Food Prices Give Shoppers Indigestion
Beware the Dangers of Social Media Lifestyle Inflation
Can a Robot Manage Your Investments Better Than a Human?
Is Celgene the Perfect Stock?
Biotechnology company Celgene (CELG) announced it is buying Abraxis BioScience (ABII) for $2.9 billion in cash and stock. With this acquisition, Ceglene is expanding its portfolio of cancer treatments.